Stéphane De Wit

8.0k total citations · 2 hit papers
66 papers, 4.2k citations indexed

About

Stéphane De Wit is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Stéphane De Wit has authored 66 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 26 papers in Epidemiology and 22 papers in Emergency Medicine. Recurrent topics in Stéphane De Wit's work include HIV/AIDS drug development and treatment (25 papers), HIV-related health complications and treatments (21 papers) and HIV/AIDS Research and Interventions (21 papers). Stéphane De Wit is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), HIV-related health complications and treatments (21 papers) and HIV/AIDS Research and Interventions (21 papers). Stéphane De Wit collaborates with scholars based in Belgium, United Kingdom and France. Stéphane De Wit's co-authors include Jens Lundgren, Bruno Ledergerber, Peter Reiss, Ole Kirk, Antonella d’Arminio Monforte, Caroline Sabin, Matthew Law, Rainer Weber, Nina Friis‐Møller and Nathan Clumeck and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

Stéphane De Wit

61 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

2008 1.2k citations Lewis H. Kuller, Russell P. Tracy et al. PLoS Medicine profile →
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

2009 481 citations Signe Westring Worm, Caroline Sabin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphane De Wit Belgium	22	2.5k	2.4k	1.6k	1.3k	596	66	4.2k
Stéphane De Wit Belgium	31	2.5k 1.0×	3.0k 1.2×	1.4k 0.9×	1.1k 0.8×	344 0.6×	98	4.3k
Philippe Morlat France	33	2.1k 0.8×	1.5k 0.6×	1.0k 0.7×	1.8k 1.3×	953 1.6×	109	4.2k
Marc van der Valk Netherlands	39	2.6k 1.0×	1.3k 0.5×	1.9k 1.2×	1.6k 1.2×	1.0k 1.7×	212	4.6k
Jacqueline Neuhaus United States	24	2.2k 0.9×	2.8k 1.1×	1.9k 1.2×	981 0.7×	158 0.3×	38	4.2k
Nina Friis‐Møller Denmark	29	3.7k 1.5×	4.5k 1.9×	2.2k 1.4×	1.1k 0.9×	320 0.5×	57	5.9k
Kathleen C. Wood United States	20	2.2k 0.9×	1.5k 0.6×	1.2k 0.8×	1.3k 1.0×	339 0.6×	29	3.3k
David A. Cooper Australia	39	5.5k 2.2×	1.4k 0.6×	4.4k 2.8×	1.6k 1.2×	633 1.1×	118	7.1k
Sheldon T. Brown United States	34	1.7k 0.7×	1.1k 0.5×	467 0.3×	2.1k 1.6×	509 0.9×	113	4.0k
Leonardo Calza Italy	30	1.6k 0.6×	1.4k 0.6×	882 0.6×	578 0.4×	193 0.3×	197	2.7k
Daniel E. Nixon United States	18	1.6k 0.6×	2.0k 0.8×	1.7k 1.1×	1.0k 0.8×	150 0.3×	32	3.3k

Countries citing papers authored by Stéphane De Wit

Since Specialization

Citations

This map shows the geographic impact of Stéphane De Wit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane De Wit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane De Wit more than expected).

Fields of papers citing papers by Stéphane De Wit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane De Wit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane De Wit. The network helps show where Stéphane De Wit may publish in the future.

Co-authorship network of co-authors of Stéphane De Wit

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane De Wit. A scholar is included among the top collaborators of Stéphane De Wit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane De Wit. Stéphane De Wit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dorman, Alexandra, Paolo Maiuri, Monika Bociąga‐Jasik, et al.. (2025). Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency. Nature Communications. 16(1). 2078–2078. 1 indexed citations

Bartiaux, Magali, et al.. (2020). Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims. Sexually Transmitted Infections. 97(5). 329–333. 5 indexed citations

Gennotte, Anne-Françoise, et al.. (2017). Adherence to HIV post-exposure prophylaxis: A multivariate regression analysis of a 5 years prospective cohort. Journal of Infection. 76(1). 78–85. 21 indexed citations

Kumar, Amit, Wasim Abbas, Sophie Bouchat, et al.. (2016). Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors. Scientific Reports. 6(1). 38313–38313. 10 indexed citations

Heurck, Roxane Van, M. C. Payen, Stéphane De Wit, & Nathan Clumeck. (2013). EPIDEMIOLOGY OF MDR-TB IN A BELGIAN INFECTIOUS DISEASES UNIT: A 15 YEARS REVIEW. Acta Clinica Belgica. 68(5). 321–324. 5 indexed citations

Monforte, Antonella d’Arminio, Peter Reiss, Lene Ryom, et al.. (2012). Atazanavir (ATV)-containing Antiretroviral Treatment is not Associated with an Increased risk of Cardio- or Cerebro- Vascular Events (CVE) in the D:A:D Study. 2 indexed citations

Wit, Stéphane De, et al.. (2012). Comparison of Demographic Characteristics and Upper Gastrointestinal Endoscopy Findings in HIV‐Positive, Antiretroviral‐Treated Patients With and Without Helicobacter pylori Coinfection. Helicobacter. 17(2). 153–159. 6 indexed citations

Kowalska, Justyna, Nina Friis‐Møller, Ole Kirk, et al.. (2011). The Coding Causes of Death in HIV (CoDe) Project. Epidemiology. 22(4). 516–523. 111 indexed citations

Soriano, Vincent, Daniel Grint, Antonella d’Arminio Monforte, et al.. (2011). DELTA HEPATITIS IN HIV-INFECTED INDIVIDUALS IN EUROPE. Hepatology. 54. 2 indexed citations

10.

Soriano, Vincent, Daniel Grint, Antonella d’Arminio Monforte, et al.. (2011). Hepatitis delta in HIV-infected individuals in Europe. AIDS. 25(16). 1987–1992. 69 indexed citations

11.

Covens, Kris, Kabamba Kabeya, Yoeri Schrooten, et al.. (2009). Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes. Journal of Clinical Virology. 44(4). 325–328. 7 indexed citations

12.

Castaigne, Cathérine, et al.. (2009). Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nuclear Medicine Communications. 30(1). 41–47. 37 indexed citations

13.

Kuller, Lewis H., Russell P. Tracy, Waldo Belloso, et al.. (2008). Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. PLoS Medicine. 5(10). e203–e203. 1231 indexed citations breakdown →

14.

Mocroft, Amanda, Vincent Soriano, Jürgen K. Rockstroh, et al.. (2005). Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?. AIDS. 19(18). 2117–2125. 112 indexed citations

15.

Konopnicki, Déborah, Amanda Mocroft, Stéphane De Wit, et al.. (2005). Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 19(6). 593–601. 429 indexed citations

16.

Clumeck, Nathan, Stéphane De Wit, Philippe Hermans, et al.. (2003). European guidelines for the clinical management and treatment of HIV-infected adults in Europe. AIDS. 17. 43 indexed citations

17.

Law, Matthew, Nina Friis‐Møller, Rainer Weber, et al.. (2003). Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study. HIV Medicine. 4(1). 1–10. 199 indexed citations

18.

Denning, David W., B. Dupont, Nathan Clumeck, et al.. (1998). Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal. AIDS. 12(4). 411–416. 7 indexed citations

19.

Wit, Stéphane De, et al.. (1997). A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS. Biomedicine & Pharmacotherapy. 51(10). 439–445. 17 indexed citations

20.

Clumeck, Nathan, et al.. (1992). Recombinant Granulocyte Colony-stimulating Factor (rG-CSF) in HIV Patients with Zidovudine Related Neutropenia. Journal of Nutritional Science and Vitaminology. 38(Special). 353–356. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact